Opening question: When a peptide ad flashes a Manhattan plot, cites a “GWAS hit,” or leans on NHGRI-EBI GWAS Catalog–looking SNP–trait screenshots, how do you tell that catalog from proof that a research peptide treats a trait or is cleared for people?
Short answer: open the GWAS Catalog About page and the Methods documentation. The Catalog—founded by NHGRI and delivered with EMBL-EBI—provides a consistent, searchable, freely available database of SNP–trait associations from genome-wide association studies, plus a large repository of full genome-wide summary statistics. A curated association record is population-genetics literacy. It is not a certificate that a research-catalog peptide treats disease or is authorised for human use.
A practical GWAS Catalog checklist when ads lean on association screenshots:
- What the Catalog is for: Systematically identifying eligible published (and some unpublished) GWAS, extracting reported traits, significant SNP–trait associations, and sample metadata so researchers can find and reuse results—not approving peptide products.
- Curation ≠ product clearance: About and Methods pages describe literature search, curator assessment, and bi-weekly data release. That workflow catalogues published associations; it does not authorise a vial for human use.
- SNP–trait link ≠ peptide efficacy: A significant association between a common variant and a complex trait in a GWAS does not mean an advertiser’s research peptide was tested against that trait in people, dosed safely, or regulator-cleared.
- Summary statistics files: Downloadable genome-wide summary statistics support research re-analysis. File availability is open-data literacy, not medicine approval.
- What to open next: Use the Catalog’s About and Methods pages to understand SNP–trait resources, keep research catalogs separate from clinical claims, and do not treat Manhattan plots as dosing or human-use evidence.
None of those steps turns a laboratory research listing into an approved medicine. Company research-only catalogs document laboratory intent and paperwork such as certificates of analysis; they do not create human-use approval. For company facts only—not clinical evidence—Apollo Peptides states products are for laboratory research only, not for human or veterinary use, and describes third-party testing with certificates of analysis.
Bottom line: Use the GWAS Catalog About page to understand SNP–trait association archives, then ask whether the ad is explaining genetics resources or implying a research peptide is clinically validated because a Manhattan plot looks official. That habit helps you notice overclaiming—it is not advice to buy, inject, or dose any peptide.
By The Everyday Brief · AI-assisted editorial. Drafted with AI research assistance; claims checked against GWAS Catalog About and Methods pages (fetched 2026-09-24 PT). No invented studies, quotes, or dosing. Not medical or legal advice.
Sources
1. NHGRI-EBI GWAS Catalog — About
2. NHGRI-EBI GWAS Catalog — Methods
3. NHGRI-EBI GWAS Catalog — Home
4. Apollo Peptides (company facts only)
Related reading
How to use Open Targets when ads flash target–disease scores